NeuMoDx Molecular Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Detroit, MI USA
Total Funding:N/A
Industry:Medical Equip
Founded:N/A
Lead Investor(s):Pfizer Ventures, Baird Capital

Industry Ranking

Estimated Revenue & Financials

  • NeuMoDx Molecular's estimated annual revenue is currently $18.6M per year.
  • NeuMoDx Molecular received $20.0M in venture funding in May 2016.
  • NeuMoDx Molecular's estimated revenue per employee is $251,000

Employee Data

  • NeuMoDx Molecular has 74 Employees.
  • NeuMoDx Molecular grew their employee count by 28% last year.
  • NeuMoDx Molecular currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingPricing
Mopec
$14.8M59N/AN/AN/A
InfuSystem
N/A202N/AN/AN/A
Xoran Technolog...
$20.8M834%N/AN/A
Skytron
$43.4M173N/AN/AN/A
CFI Medical Sol...
$7M28N/AN/AN/A
Art Optical Con...
$6.3M25N/AN/AN/A
Advance Turning...
$16.3M658%N/AN/A
Medbio
$26.4M1054%N/AN/A
Autocam Medical
$62.8M2506%N/AN/A
Alliant Healthc...
$11.3M45N/AN/AN/A
Missing a competitor? Contribute!?
Submit

keywords:B2B

74

Number of Employees

$18.6M

Revenue (est)

1

Current Jobs

28%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Executive Contacts

NameTitleEmail
Jeff WilliamsCEO/ChairmanEmail Available
Sundu BrahmasandraPresident and COO, NeuMoDx MolecularEmail Available
Jeff WilliamsChairman and CEOEmail Available
Manjeet SandhuBusiness Development ManagerEmail Available
John NeisserBusiness Development Manager at NeuMoDx MolecularEmail Available
Dawn WinderSr. Director of QualityEmail Available
Dan HarmaChief Commercial OfficerEmail Available
Marlo IvesReagent Production ManagerEmail Available
Dominick PennellaDirector Of Customer ServicesEmail Available
Jennifer RuthClinical Affairs ManagerEmail Available

NeuMoDx Molecular News

08/12/2019 - NeuMoDx Files Defense, Counterclaims in BD Patent ...

NEW YORK – NeuMoDx has filed a response with the District of ... by Becton Dickinson that the molecular diagnostics developer infringed on ...

09/05/2019 - Global Biochips Market Overview 2019: Market Value ...

1.1.8.2.1.1 Lab-on-a-chip and Molecular Biology ... Cancer Therapy; QIAGEN NV Selects NeuMoDx Molecular, Inc for CE-IVD Assays Purchase ...

04/11/2019 - QIAGEN and NeuMoDx expand assay menu for their next ...

BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) and NeuMoDx Molecular, Inc. today announced an expansion ...

NeuMoDx Molecular Funding

DateAmountRoundLead InvestorsReference
2014-03-28$10.5MUndisclosedArticle
2014-04-02$21.0MBPfizer VenturesArticle
2016-05-03$20.0MUndisclosedArticle